On October 10, 2024, a delegation from AMA Association of Makassar, Indonesia, visited St. Stamford Modern Cancer Hospital Guangzhou. The purpose of the visit was to enhance understanding of St. Stamford Modern Cancer Hospital Guangzhou, promote cooperation and exchanges between the two parties, and encourage the development of health services in Makassar to benefit the local community.

On the afternoon of the 9th, Wang Huaizhong(President of St. Stamford Modern Cancer Hospital Guangzhou), along with He Langbing（Director of International Affairs), Yang Jinna (Director of the Hospital Office), and other leaders, warmly welcomed the delegation from Makassar and provided them with a cordial reception.

In his speech, President Wang stated, "Since its establishment, our hospital has been committed to the development of overseas business. Our patients are located across Malaysia, Thailand, Vietnam, the Philippines, and other countries. Our relationship with Indonesia has been established for nearly 20 years, with about 20,000 cancer patients from Indonesia being served. We offer the most advanced minimally invasive tumor technology at present and have established a comprehensive service system for patients with mid- and late-stage cancer. We prioritize the humanistic care of our patients, placing their physical and mental well-being at the forefront to ensure a worry-free treatment process that achieves optimal therapeutic outcomes. I hope that through this exchange, more people will come to understand our mission, enabling the hospital to extend its services to more cancer patients in need."

To enhance the delegates’ understanding of the hospital, the hospital leaders prepared a live broadcast of the Minimally Invasive Interventional treatment procedure and an on-site observation of the Seed Implantation procedure. Dr. Ban Zhonghua, Head of the Interventional Treatment Room, and Dr. He Jianyu, Head of the Minimally Invasive Treatment Room, provided the delegates with a detailed explanation of the technical principles of minimally invasive treatment, precautions, and the diseases for which these treatments are applicable. Additionally, the delegates gained a profound understanding of our hospital’s MDT diagnosis and treatment model, the holistic integrative oncology minimally invasive treatment system, and the green therapy combining Eastern and Western medicine, which were presented by Professor Song Shijun, the chief expert and assistant director of the hospital.

In addition, Liu Yansheng, the assistant director of the International Affairs Department, led the delegation to visit the hospital. The delegation learned about the overall layout of the facility and toured various departments, including the oncology wards, minimally invasive treatment operating rooms, patient wards, public dining rooms, remote consultation centers, and sky gardens. Assistant Liu highlighted the remote consultation center, stating, "Our hospital's remote consultation center was established in 2016. International patients can consult our experts 'face to face' via the Internet, allowing them to receive professional and personalized treatment plans without the need to travel abroad.

At the end of the visit, the delegation went to meet with Ms. Zhang, a lung cancer patient from Indonesia. Ms. Zhang expressed her gratitude for the arrival of the medical team, stating, "Thank you all for visiting me. I am feeling much better now. The doctors and nurses at the hospital are very considerate. The service is exceptionally thoughtful, and the arrangements for food, clothing, accommodation, and transportation are very appropriate. I feel incredibly fortunate to receive treatment at St. Stamford Modern Cancer Hospital Guangzhou."

The chairman of AMA Makassar stated, "This visit has made me realize that St. Stamford Modern Cancer Hospital Guangzhou is a very superior team, in terms of service, medical technology, and the overall hospital facilities. The advanced international cancer treatment technology in this hospital is truly impressive and far surpasses those found in Indonesia and many other Asian countries. The number of cancer patients in Indonesia is on the rise, while the development and standards of medical technology urgently require improvement. Today, I witnessed the advanced minimally invasive treatments offered at this hospital and the results of patient treatment. This experience has heightened my expectations for the advancement of healthcare services in Indonesia. I hope we can enhance communication and collaboration with this hospital to save more cancer patients in Indonesia."